Proliferative potentials of intracranial chordomas with a reference to extracranial chordomas

被引:1
|
作者
Matsuno, A
Sasaki, T
Nagashima, T
Kirino, T
Osamura, RY
机构
[1] Teikyo Univ, Ichihara Hosp, Dept Neurosurg, Ichihara, Chiba 2990111, Japan
[2] Gunma Univ, Sch Med, Dept Neurosurg, Gunma 3718511, Japan
[3] Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan
[4] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591100, Japan
关键词
intracranial chordoma; proliferative potential; MIB-1; p53; protein; recurrence;
D O I
10.1267/ahc.34.305
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Some intracranial chordomas are known to have frequent recurrence in their clinical course. The biological features regulating recurrence of intracranial chordomas has not been elucidated. We studied the proliferative potentials of chordomas with an immunohistochemical staining method using anti-Ki-67 antibody, MIB-1, together with an immunohistochemical examination on the expression of p53 protein. The correlation among MIB-1 staining indices, the immunoreactivities of p53 protein and clinical courses of intracranial chordomas was analyzed retrospectively, and the statistically significant correlation between MIB-1 staining index (SI) and recurrence has been clarified. The mean MIB-1 SI of recurrent tumors was 10.2%, which was higher than that of non-recurrent tumors (2.8%). The p53 immunopositivity correlated well with recurrence and high MIB-1 SI. Literature review also showed the importance of MIB-1 Sl and p53 overexpression in extracranial chordomas. In conclusion, both the examination on proliferative potentials of chordomas using MIB-1 Sl and the study on the immunoreactivity of p53 protein, are important for their biological and histopathological analyses and the prediction of future recurrence.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 50 条
  • [1] Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery
    Jiang, Bowen
    Veeravagu, Arland
    Lee, Marco
    Harsh, Griffith R.
    Lieberson, Robert E.
    Bhatti, Inderpreet
    Soltys, Scott G.
    Gibbs, Iris C.
    Adler, John R.
    Chang, Steven D.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (08) : 1101 - 1106
  • [2] INTRACRANIAL CHORDOMAS
    DANZIGER, J
    LEWERALL.K
    BLOCH, S
    CLINICAL RADIOLOGY, 1974, 25 (03) : 309 - 316
  • [3] INTRACRANIAL CHORDOMAS
    SCHECHTER, MM
    LIEBESKIND, AL
    AZARKIA, B
    NEURORADIOLOGY, 1974, 8 (02) : 67 - 82
  • [4] Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas
    Matsuno, A
    Sasaki, T
    Nagashima, T
    Matsuura, R
    Tanaka, H
    Hirakawa, M
    Murakami, M
    Kirino, T
    HUMAN PATHOLOGY, 1997, 28 (06) : 714 - 719
  • [5] Pediatric intracranial chordomas - Response
    AlMefty, O
    JOURNAL OF NEUROSURGERY, 1996, 85 (05) : 990 - 990
  • [6] Endoscopic endonasal approach for intracranial chordomas
    Chakraborty, Shamik
    Dehdashti, Amir R.
    ACTA NEUROCHIRURGICA, 2017, 159 (10) : 1847 - 1848
  • [7] Endoscopic endonasal approach for intracranial chordomas
    Shamik Chakraborty
    Amir R. Dehdashti
    Acta Neurochirurgica, 2017, 159 : 1847 - 1848
  • [8] Predictors of recurrence following resection of intracranial chordomas
    Choy, Winward
    Terterov, Sergei
    Kaprealian, Tania B.
    Trang, Andy
    Ung, Nolan
    DeSalles, Antonio
    Chung, Lawrance K.
    Martin, Neil
    Selch, Michael
    Bergsneider, Marvin
    Vinters, Harry V.
    Yong, William H.
    Yang, Isaac
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (11) : 1792 - 1796
  • [9] CHORDOMAS
    LECHARPENTIER, Y
    BELLEFQIH, S
    BOISNIC, S
    ROYCAMILLE, R
    ANNALES DE PATHOLOGIE, 1988, 8 (01) : 25 - 32
  • [10] Chordomas
    Riopel, Celine
    Michot, Chantal
    ANNALES DE PATHOLOGIE, 2007, 27 (01) : 6 - 15